Table 3.
Expected costs and effects for the predefined patient subgroups
| Subgroup | Manual palpation strategy | Modified TEE strategy | Modified TEE vs Manual palpation | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
Gender |
Age |
% atherosclerosis |
Expectedcosts (€) |
Expected effects(QALY) |
Expectedcosts(€) |
Expectedeffects(QALY) |
Expectedincremental costs (€) |
Expectedincrementaleffects (QALY) |
ExpectedICER(€ / QALY) |
| 1 |
Men |
55 yr |
10% |
25,896 |
14.31 |
25,943 |
14.32 |
47 |
0.01 |
4,651 |
| 2 |
Men |
55 yr |
15% |
25,936 |
14.31 |
25,970 |
14.32 |
34 |
0.01 |
3,376 |
| 3 |
Women |
55 yr |
10% |
25,984 |
15.34 |
25,993 |
15.36 |
10 |
0.02 |
481 |
| 4 |
Women |
55 yr |
15% |
26,012 |
15.33 |
26,009 |
15.36 |
−3 |
0.03 |
−103* |
|
5 |
Men |
65 yr |
20% |
26,589 |
10.75 |
26,581 |
10.77 |
−8 |
0.02 |
−420* |
| 6 |
Men |
65 yr |
30% |
26,671 |
10.74 |
26,639 |
10.76 |
−32 |
0.02 |
−1,603* |
|
7 |
Women |
65 yr |
20% |
26,720 |
11.83 |
26,662 |
11.86 |
−58 |
0.03 |
−1,946* |
| 8 |
Women |
65 yr |
30% |
26,815 |
11.80 |
26,722 |
11.84 |
−93 |
0.04 |
−2,318* |
| 9 |
Men |
75 yr |
40% |
27,629 |
7.01 |
27,479 |
7.04 |
−149 |
0.03 |
−4,973* |
| 10 |
Men |
75 yr |
50% |
27,733 |
6.99 |
27,547 |
7.03 |
−186 |
0.04 |
−4,648* |
| 11 |
Women |
75 yr |
40% |
28,563 |
8.10 |
28,182 |
8.15 |
−380 |
0.05 |
−7,608* |
| 12 | Women | 75 yr | 50% | 28,719 | 8.08 | 28,264 | 8.14 | −455 | 0.06 | −7,579* |
Cost and effect outcomes for each of the 12 predefined patient subgroups (see text). For both strategies the costs and effects are given, as well as the incremental costs and effects and the incremental cost-effectiveness ratio (ICER).
* In this scenario the modified TEE strategy dominated the manual palpation strategy.